• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨病原体种群密度作为理解新冠后传染病激增的指标。

Exploring pathogen population density as a metric for understanding post-COVID infectious disease surges.

机构信息

School of Biological Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, NE, United States.

出版信息

Front Immunol. 2024 Oct 3;15:1459628. doi: 10.3389/fimmu.2024.1459628. eCollection 2024.

DOI:10.3389/fimmu.2024.1459628
PMID:39421748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11484442/
Abstract

After the easing of COVID-19 restrictions, peaks of common infectious diseases surpassed pre-pandemic levels, raising questions about causes and ways to monitor these changes. A proposed measure, the Pathogen Population Density (PPD) score, could help track these shifts. PPD refers to the concentration of infectious agents within a population at a given time and location, serving as a potential indicator of infection levels in susceptible individuals at the population level. It is likely that PPD remains relatively stable within a specific community, as an equilibrium forms between infections and susceptibility. During the pandemic, nonpharmaceutical interventions (NPIs) led to a reduction in infectious diseases, possibly lowering population immunity and decreasing the PPD score. Once NPIs were lifted, the PPD score likely increased sharply due to a larger pool of susceptible individuals, causing more primary infections and stronger recurrent infections, faster transmission, and more severe pathogenic outcomes at the individual level. Monitoring the PPD score over time could help predict when infection peaks will occur. PPD is influenced by factors such as public health strategies, vaccination programs, and the behavior of high-risk individuals. As a quantitative measure, PPD has the potential to serve as a valuable predictive and monitoring tool, helping public health officials anticipate and track changes in infectious disease dynamics. It could be an effective tool for managing future outbreaks or pandemics and serve as a communication tool between scientists and the public to understand the emergence of new disease peaks.

摘要

在 COVID-19 限制措施放宽后,常见传染病的高峰超过了大流行前的水平,这引发了人们对这些变化的原因和监测方法的质疑。一个被提议的衡量标准,病原体种群密度(PPD)评分,可能有助于跟踪这些变化。PPD 是指在特定时间和地点内人群中传染性病原体的浓度,它是人群中易感个体感染水平的潜在指标。在特定社区内,PPD 可能相对稳定,因为感染和易感性之间会形成平衡。在大流行期间,非药物干预(NPIs)导致传染病减少,可能降低了人群免疫力并降低了 PPD 评分。一旦 NPIs 被取消,由于易感个体数量增加,PPD 评分可能会急剧上升,导致更多的原发性感染和更强的复发性感染、更快的传播速度以及个体层面更严重的致病性后果。随着时间的推移监测 PPD 评分可以帮助预测感染高峰何时发生。PPD 受到公共卫生策略、疫苗接种计划和高风险个体行为等因素的影响。作为一种定量衡量标准,PPD 有可能成为一种有价值的预测和监测工具,帮助公共卫生官员预测和跟踪传染病动态的变化。它可以是管理未来疫情爆发或大流行的有效工具,并作为科学家和公众之间的沟通工具,以了解新的疾病高峰的出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa6/11484442/8f597715f804/fimmu-15-1459628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa6/11484442/8f597715f804/fimmu-15-1459628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6aa6/11484442/8f597715f804/fimmu-15-1459628-g001.jpg

相似文献

1
Exploring pathogen population density as a metric for understanding post-COVID infectious disease surges.探讨病原体种群密度作为理解新冠后传染病激增的指标。
Front Immunol. 2024 Oct 3;15:1459628. doi: 10.3389/fimmu.2024.1459628. eCollection 2024.
2
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?解除新冠肺炎大流行后的非药物干预措施——暴风雨前的宁静?
Expert Rev Vaccines. 2022 Nov;21(11):1541-1553. doi: 10.1080/14760584.2022.2117693. Epub 2022 Sep 5.
3
Within-host diversity improves phylogenetic and transmission reconstruction of SARS-CoV-2 outbreaks.宿主内多样性提高了 SARS-CoV-2 爆发的系统发育和传播重建。
Elife. 2023 Sep 21;12:e84384. doi: 10.7554/eLife.84384.
4
Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States.量化 COVID-19 非药物干预措施对美国流感传播的影响。
J Infect Dis. 2021 Nov 16;224(9):1500-1508. doi: 10.1093/infdis/jiab485.
5
The devil in the details: Herd immunity and pandemic response.细节中的魔鬼:群体免疫与大流行应对。
Cell Host Microbe. 2021 Jul 14;29(7):1048-1051. doi: 10.1016/j.chom.2021.06.017.
6
The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.新冠病毒严重感染高风险的5%人群是可识别的,在经济重启时需要予以考虑。
J Psychiatr Pract. 2020 May;26(3):219-227. doi: 10.1097/PRA.0000000000000475.
7
Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.新冠疫情期间韩国人间和动物间法定传染病的流行趋势
Emerg Infect Dis. 2024 Jun;30(6):1154-1163. doi: 10.3201/eid3006.231422.
8
Prevalence of Common Infectious Diseases After COVID-19 Vaccination and Easing of Pandemic Restrictions in Israel.以色列在 COVID-19 疫苗接种后常见传染病的流行率和大流行限制放宽后。
JAMA Netw Open. 2022 Feb 1;5(2):e2146175. doi: 10.1001/jamanetworkopen.2021.46175.
9
Long-term effects of non-pharmaceutical interventions on total disease burden in parsimonious epidemiological models.简约流行病学模型中非药物干预对总疾病负担的长期影响。
J Theor Biol. 2024 Jun 21;587:111817. doi: 10.1016/j.jtbi.2024.111817. Epub 2024 Apr 9.
10
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.

本文引用的文献

1
Increase in acute mastoiditis at the end of the COVID-19 pandemic.COVID-19 大流行末期急性乳突炎的增加。
Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4747-4756. doi: 10.1007/s00405-024-08704-y. Epub 2024 May 14.
2
Rapid expansion and international spread of M1 in the post-pandemic UK upsurge of Streptococcus pyogenes.在新冠疫情后英国链球菌急剧上升期间,M1 型在英国迅速扩张和国际传播。
Nat Commun. 2024 May 10;15(1):3916. doi: 10.1038/s41467-024-47929-7.
3
Measles Vaccine Coverage and Disease Outbreaks: A Systematic Review of the Early Impact of COVID-19 in Low and Lower-Middle Income Countries.
麻疹疫苗接种率和疾病暴发:COVID-19 对低收入和中低收入国家早期影响的系统评价。
Int J Public Health. 2024 Apr 25;69:1606997. doi: 10.3389/ijph.2024.1606997. eCollection 2024.
4
From imprecise "immune debt" to nuanced "immune shortage"?从不精确的“免疫债”到细致入微的“免疫不足”?
Infect Dis Now. 2024 Aug;54(5):104894. doi: 10.1016/j.idnow.2024.104894. Epub 2024 Mar 27.
5
A Review of the Resurgence of Measles, a Vaccine-Preventable Disease, as Current Concerns Contrast with Past Hopes for Measles Elimination.麻疹卷土重来的研究综述,一种可通过疫苗预防的疾病,目前的担忧与过去消除麻疹的期望形成鲜明对比。
Med Sci Monit. 2024 Mar 13;30:e944436. doi: 10.12659/MSM.944436.
6
Immune damage in Long Covid.长新冠中的免疫损伤。
Science. 2024 Jan 19;383(6680):262-263. doi: 10.1126/science.adn1077. Epub 2024 Jan 18.
7
The Effects of Non-Pharmaceutical Interventions on COVID-19 Cases, Hospitalizations, and Mortality: A Systematic Literature Review and Meta-Analysis.非药物干预对新冠病毒疾病病例、住院率和死亡率的影响:一项系统文献综述与荟萃分析
AJPM Focus. 2023 Jun 14;2(4):100125. doi: 10.1016/j.focus.2023.100125.
8
Herd immunity, vaccination and moral obligation.群体免疫、疫苗接种和道德义务。
J Med Ethics. 2023 Sep;49(9):636-641. doi: 10.1136/jme-2022-108485. Epub 2023 Jun 5.
9
From rare disorders of immunity to common determinants of infection: Following the mechanistic thread.从罕见的免疫紊乱到常见的感染决定因素:追寻机制线索。
Cell. 2022 Aug 18;185(17):3086-3103. doi: 10.1016/j.cell.2022.07.004.
10
The Vaccine-Hesitant Moment.对疫苗犹豫不决的时刻。
N Engl J Med. 2022 Jul 7;387(1):58-65. doi: 10.1056/NEJMra2106441. Epub 2022 Jun 29.